Selected research
Market Structure
Global Viral Vector Purification Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Viral Vector Purification Media market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Viral Vector Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Viral Vector Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Viral Vector Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Viral Vector Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Viral Vector Purification Media include Cytiva, Thermo Fisher Scientific, Repligen, Sartorius, Bio-Rad, Merck, Tosoh Bioscience, Astrea Bioseparations and JNC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Viral Vector Purification Media output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Viral Vector Purification Media by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Viral Vector Purification Media market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Viral Vector Purification Media and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Viral Vector Purification Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Viral Vector Purification Media market size, projected growth trends, production technologies, key applications, and end-use industries.
Viral Vector Purification Media Segment by Company
Cytiva
Thermo Fisher Scientific
Repligen
Sartorius
Bio-Rad
Merck
Tosoh Bioscience
Astrea Bioseparations
JNC
Sepax Technologies
Sunresin
Bestchrom
NanoMicro
BioToolomics
Viral Vector Purification Media Segment by Type
AAV Affinity Media
Anion Exchange Media
Cation Exchange Media
Mixed-Mode Media
Core-Bead Flow-Through Media
Monolith and Membrane Adsorbers
Viral Vector Purification Media Segment by Application
AAV Gene Therapy Vector Production
Lentiviral Vector Production
Adenoviral Vector and Vaccine Production
Oncolytic Virus and VLP Production
Process Development and Scale-Up
QC and Analytical Sample Preparation
Viral Vector Purification Media Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Vector Purification Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Vector Purification Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Vector Purification Media.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Viral Vector Purification Media market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viral Vector Purification Media industry.
Chapter 3: Detailed analysis of Viral Vector Purification Media market competition landscape. Including Viral Vector Purification Media manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Viral Vector Purification Media by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Viral Vector Purification Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- AAV Affinity Media
- Anion Exchange Media
- Cation Exchange Media
- Mixed-Mode Media
- Core-Bead Flow-Through Media
- Monolith and Membrane Adsorbers
Applications
- AAV Gene Therapy Vector Production
- Lentiviral Vector Production
- Adenoviral Vector and Vaccine Production
- Oncolytic Virus and VLP Production
- Process Development and Scale-Up
- QC and Analytical Sample Preparation
Companies covered
- Cytiva
- Thermo Fisher Scientific
- Repligen
- Sartorius
- Bio-Rad
- Merck
- Tosoh Bioscience
- Astrea Bioseparations
- JNC
- Sepax Technologies
- Sunresin
- Bestchrom
- NanoMicro
- BioToolomics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Viral Vector Purification Media Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Viral Vector Purification Media Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Viral Vector Purification Media Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Viral Vector Purification Media Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Viral Vector Purification Media Market Dynamics
- 2.1 Viral Vector Purification Media Industry Trends
- 2.2 Viral Vector Purification Media Industry Drivers
- 2.3 Viral Vector Purification Media Industry Opportunities and Challenges
- 2.4 Viral Vector Purification Media Industry Restraints
3 Viral Vector Purification Media Market by Manufacturers
- 3.1 Global Viral Vector Purification Media Production Value by Manufacturers (2021-2026)
- 3.2 Global Viral Vector Purification Media Production by Manufacturers (2021-2026)
- 3.3 Global Viral Vector Purification Media Average Price by Manufacturers (2021-2026)
- 3.4 Global Viral Vector Purification Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Viral Vector Purification Media Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Viral Vector Purification Media Manufacturers, Product Type & Application
- 3.7 Global Viral Vector Purification Media Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Viral Vector Purification Media Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Viral Vector Purification Media Players Market Share by Production Value in 2025
- 3.8.3 2025 Viral Vector Purification Media Tier 1, Tier 2, and Tier 3
4 Viral Vector Purification Media Market by Type
- 4.1 Viral Vector Purification Media Type Introduction
- 4.1.1 AAV Affinity Media
- 4.1.2 Anion Exchange Media
- 4.1.3 Cation Exchange Media
- 4.1.4 Mixed-Mode Media
- 4.1.5 Core-Bead Flow-Through Media
- 4.1.6 Monolith and Membrane Adsorbers
- 4.2 Global Viral Vector Purification Media Production by Type
- 4.2.1 Global Viral Vector Purification Media Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Viral Vector Purification Media Production by Type (2021-2032)
- 4.2.3 Global Viral Vector Purification Media Production Market Share by Type (2021-2032)
- 4.3 Global Viral Vector Purification Media Production Value by Type
- 4.3.1 Global Viral Vector Purification Media Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Viral Vector Purification Media Production Value by Type (2021-2032)
- 4.3.3 Global Viral Vector Purification Media Production Value Market Share by Type (2021-2032)
5 Viral Vector Purification Media Market by Application
- 5.1 Viral Vector Purification Media Application Introduction
- 5.1.1 AAV Gene Therapy Vector Production
- 5.1.2 Lentiviral Vector Production
- 5.1.3 Adenoviral Vector and Vaccine Production
- 5.1.4 Oncolytic Virus and VLP Production
- 5.1.5 Process Development and Scale-Up
- 5.1.6 QC and Analytical Sample Preparation
- 5.2 Global Viral Vector Purification Media Production by Application
- 5.2.1 Global Viral Vector Purification Media Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Viral Vector Purification Media Production by Application (2021-2032)
- 5.2.3 Global Viral Vector Purification Media Production Market Share by Application (2021-2032)
- 5.3 Global Viral Vector Purification Media Production Value by Application
- 5.3.1 Global Viral Vector Purification Media Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Viral Vector Purification Media Production Value by Application (2021-2032)
- 5.3.3 Global Viral Vector Purification Media Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Cytiva
- 6.1.1 Cytiva Company Information
- 6.1.2 Cytiva Business Overview
- 6.1.3 Cytiva Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.1.4 Cytiva Viral Vector Purification Media Product Portfolio
- 6.1.5 Cytiva Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher Scientific Viral Vector Purification Media Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 Repligen
- 6.3.1 Repligen Company Information
- 6.3.2 Repligen Business Overview
- 6.3.3 Repligen Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.3.4 Repligen Viral Vector Purification Media Product Portfolio
- 6.3.5 Repligen Recent Developments
- 6.4 Sartorius
- 6.4.1 Sartorius Company Information
- 6.4.2 Sartorius Business Overview
- 6.4.3 Sartorius Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.4.4 Sartorius Viral Vector Purification Media Product Portfolio
- 6.4.5 Sartorius Recent Developments
- 6.5 Bio-Rad
- 6.5.1 Bio-Rad Company Information
- 6.5.2 Bio-Rad Business Overview
- 6.5.3 Bio-Rad Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.5.4 Bio-Rad Viral Vector Purification Media Product Portfolio
- 6.5.5 Bio-Rad Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.6.4 Merck Viral Vector Purification Media Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Tosoh Bioscience
- 6.7.1 Tosoh Bioscience Company Information
- 6.7.2 Tosoh Bioscience Business Overview
- 6.7.3 Tosoh Bioscience Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.7.4 Tosoh Bioscience Viral Vector Purification Media Product Portfolio
- 6.7.5 Tosoh Bioscience Recent Developments
- 6.8 Astrea Bioseparations
- 6.8.1 Astrea Bioseparations Company Information
- 6.8.2 Astrea Bioseparations Business Overview
- 6.8.3 Astrea Bioseparations Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.8.4 Astrea Bioseparations Viral Vector Purification Media Product Portfolio
- 6.8.5 Astrea Bioseparations Recent Developments
- 6.9 JNC
- 6.9.1 JNC Company Information
- 6.9.2 JNC Business Overview
- 6.9.3 JNC Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.9.4 JNC Viral Vector Purification Media Product Portfolio
- 6.9.5 JNC Recent Developments
- 6.10 Sepax Technologies
- 6.10.1 Sepax Technologies Company Information
- 6.10.2 Sepax Technologies Business Overview
- 6.10.3 Sepax Technologies Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.10.4 Sepax Technologies Viral Vector Purification Media Product Portfolio
- 6.10.5 Sepax Technologies Recent Developments
- 6.11 Sunresin
- 6.11.1 Sunresin Company Information
- 6.11.2 Sunresin Business Overview
- 6.11.3 Sunresin Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.11.4 Sunresin Viral Vector Purification Media Product Portfolio
- 6.11.5 Sunresin Recent Developments
- 6.12 Bestchrom
- 6.12.1 Bestchrom Company Information
- 6.12.2 Bestchrom Business Overview
- 6.12.3 Bestchrom Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.12.4 Bestchrom Viral Vector Purification Media Product Portfolio
- 6.12.5 Bestchrom Recent Developments
- 6.13 NanoMicro
- 6.13.1 NanoMicro Company Information
- 6.13.2 NanoMicro Business Overview
- 6.13.3 NanoMicro Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.13.4 NanoMicro Viral Vector Purification Media Product Portfolio
- 6.13.5 NanoMicro Recent Developments
- 6.14 BioToolomics
- 6.14.1 BioToolomics Company Information
- 6.14.2 BioToolomics Business Overview
- 6.14.3 BioToolomics Viral Vector Purification Media Production, Value and Gross Margin (2021-2026)
- 6.14.4 BioToolomics Viral Vector Purification Media Product Portfolio
- 6.14.5 BioToolomics Recent Developments
7 Global Viral Vector Purification Media Production by Region
- 7.1 Global Viral Vector Purification Media Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Viral Vector Purification Media Production by Region (2021-2032)
- 7.2.1 Global Viral Vector Purification Media Production by Region (2021-2026)
- 7.2.2 Global Viral Vector Purification Media Production Forecast by Region (2027-2032)
- 7.3 Global Viral Vector Purification Media Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Viral Vector Purification Media Production Value by Region (2021-2032)
- 7.4.1 Global Viral Vector Purification Media Production Value by Region (2021-2026)
- 7.4.2 Global Viral Vector Purification Media Production Value by Region (2027-2032)
- 7.5 Global Viral Vector Purification Media Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Viral Vector Purification Media Production Value (2021-2032)
- 7.6.2 Europe Viral Vector Purification Media Production Value (2021-2032)
- 7.6.3 Asia-Pacific Viral Vector Purification Media Production Value (2021-2032)
- 7.6.4 South America Viral Vector Purification Media Production Value (2021-2032)
- 7.6.5 Middle East & Africa Viral Vector Purification Media Production Value (2021-2032)
8 Global Viral Vector Purification Media Consumption by Region
- 8.1 Global Viral Vector Purification Media Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Viral Vector Purification Media Consumption by Region (2021-2032)
- 8.2.1 Global Viral Vector Purification Media Consumption by Region (2021-2026)
- 8.2.2 Global Viral Vector Purification Media Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Viral Vector Purification Media Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Viral Vector Purification Media Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Viral Vector Purification Media Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Viral Vector Purification Media Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Viral Vector Purification Media Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Viral Vector Purification Media Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Viral Vector Purification Media Value Chain Analysis
- 9.1.1 Viral Vector Purification Media Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Viral Vector Purification Media Production Mode & Process
- 9.2 Viral Vector Purification Media Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Viral Vector Purification Media Distributors
- 9.2.3 Viral Vector Purification Media Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst